Further to guidance information published at the beginning of December 2018 (and in addition to the series of technical notices on health published at the end of summer), on 20 December the Government published updated guidance for the NHS on what providers and commissioners of health and care services in England need to know and should do now to prepare for the possibility that the UK leaves the EU without a ratified deal – a "no deal" exit.
No deal operational guidance
The actions outlined in this update cover seven key areas of activity that are likely to be impacted by a "no-deal" Brexit and confirm that the health and care system should continue to prepare for a no-deal scenario as part of existing local business continuity plans. The seven areas are:
- supply of medicines and vaccines
- supply of medical devices and clinical consumables
- supply of non-clinical consumables, goods and services
- reciprocal healthcare
- research and clinical networks
- data sharing, processing and access
Read our analysis of the updated guidance (20 December 2018).
The Government also issued an amendment to the Human Medicines (Amendment) Regulations 2019, adding a Serious Shortage Protocol for potential shortages of medicines that could occur in scenarios such as a no-deal Brexit. The Protocol makes provisions for pharmacists to supply a different strength, quantity or pharmaceutical form of certain medicines in particular situations (18 January 2019). More here.